ECRM_1170x120_8-1-17

limited-distribution drugs

Drugs targeting metastatic cancers, opioid addiction now available through AllianceRx Walgreens Prime

Drugs targeting metastatic cancers, opioid addiction now available through AllianceRx Walgreens Prime

ORLANDO, Fla. — AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy, can now offer new medicines to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs, these hard-to-find medicines treat rare conditions such as advanced cancer of the stomach, community-acquired bacterial pneumonia (CABP), and opioid addiction, to name a

M&A activity heats up in specialty pharmacy

M&A activity heats up in specialty pharmacy

In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused

Diplomat steps to the fore in specialty Rx

Diplomat steps to the fore in specialty Rx

FLINT, Mich. — Diplomat Pharmacy Inc. is a growing company in a quickly growing industry. The specialty pharmacy provider has made the most of its independence, says chairman and chief executive officer Phil Hagerman, and continues to do so after last year’s initial public offering. Even though Diplomat has become publicly traded, “we absolutely still